This study aimed to demonstrate the real-life efficacy and safety of glecaprevir /pibrentasvir in the treatment of chronic hepatitis C, as well as to identify the problems caused by the COVID-19 pandemic in the follow-up and treatment of patients.
Tópico:
Hepatitis C virus research
Citaciones:
0
Citaciones por año:
No hay datos de citaciones disponibles
Altmétricas:
0
Información de la Fuente:
FuenteInfectious Diseases and Clinical Microbiology
